US Pharma MarketingThe post Leal Therapeutics raises $30m to fund schizophrenia and ALS trials appeared first on Clinical Trials Arena.
Leal Therapeutics raises $30m to fund schizophrenia and ALS trials
Leal Therapeutics has completed a $30m extension of its Series A financing to support advancement of its investigational therapies for schizophrenia and ALS through clinical trials. The post Leal Therapeutics raises $30m to fund schizophrenia and ALS trials appeared first on Clinical Trials Arena .
Leal Therapeutics has completed a $30m extension of its Series A financing to support advancement of its investigational therapies for schizophrenia and ALS through clinical trials.
Source: Clinical Trials Arena